Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07126717Not ApplicableCompleted

Acute Effects of Zynamite® S in Cognitive Function and Mood

Role: lead

NCT06463145Not ApplicableCompleted

Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People

Role: lead

NCT05580146Not ApplicableCompleted

Acute Dose-ranging Effects of Mango Leaf Extract (Zynamite® 15%) on Cognitive Function and Cerebral Blood Flow

Role: collaborator

NCT04299217Not ApplicableCompleted

Acute Effects of Mango Leaf Extract (Zynamite®) on Cognitive Function, Mood and Stress

Role: collaborator

NCT04381026Not ApplicableCompleted

Effects of a New Botanical Extracts Combination on Quality of Life in Menopausal Spanish Women

Role: lead

All 5 trials loaded